Exploring the link between autoimmune diseases and Alzheimer's Disease in diverse populations
Official title: Investigating clinical risk between autoimmunity and Alzheimer’s Disease in diverse human populations
Funded at University of California, San Francisco · NIH-10996024 · Data updated 2026-11-12
This study is looking at whether people with autoimmune diseases are more likely to develop Alzheimer's Disease, and it aims to find out how factors like gender and ethnicity might play a role, all to help improve understanding and treatment of these conditions.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | December 1, 2024 |
| Project end | November 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $45,618 |
| NIH project number | 1F31AG090013-01 |
| Project ID | NIH-10996024 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with autoimmune diseases, particularly those who are at risk for Alzheimer's Disease.
✕Less likely to help
Patients without autoimmune diseases or those already diagnosed with Alzheimer's Disease may not benefit from this research.
What this research studies
This research investigates the relationship between autoimmune diseases and the risk of developing Alzheimer's Disease (AD) by analyzing real-world clinical data from electronic health records. The study aims to determine if individuals with autoimmune conditions have a higher likelihood of developing AD, focusing on various demographic factors such as gender and ethnicity. By examining these connections, the research seeks to uncover potential shared mechanisms between autoimmune diseases and AD, which could lead to new insights into disease prevention and treatment.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of Alzheimer's Disease risk factors, potentially informing prevention strategies for at-risk populations.
How similar studies have gone: While the investigation of autoimmune diseases in relation to Alzheimer's Disease is relatively novel, there is emerging evidence suggesting immune dysfunction may play a role in neurodegenerative conditions.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Ramey, Grace — University of California, San Francisco
- Study coordinator: Ramey, Grace
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.